Pfizer Inc said on Thursday it would supply up to 6 million courses of its COVID-19 antiviral treatment to NGO Global Fund for low- and middle-income countries that seeks to address worldwide disparities in COVID response.
https://www.pharmalive.com/wp-content/uploads/2022/03/Pfizer-to-maintain-drug-supply-to-Russia-stops-new-clinical-trials-Reuters-3-14-22.jpg503960Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-09-22 06:47:132022-09-22 09:07:58Pfizer to supply up to 6 mln COVID pill courses for lower income countries
